Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
Submitted by
admin
on February 24, 2016 - 4:48pm
Source:
BioPharma Dive
News Tags:
romosozumab
Amgen
osteoporosis
clinical trials
Eli Lilly
Forteo
Radius Health
abaloparatide
Headline:
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
Do Not Allow Advertisers to Use My Personal information
